Implications of tissue specific STING protein flux and abundance on inflammation and the development of targeted therapeutics

Angel TE
February 25, 2025
PLoS One
https://pubmed.ncbi.nlm.nih.gov/39999142

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/39999142

Research summary

This study examines the tissue-specific turnover rates and abundance of the Stimulator of Interferon Genes (STING) protein in both wild-type (WT) mice and those carrying the Trex1 D18N mutation, a model for STING-dependent inflammation. The research employs metabolic labeling with deuterium oxide and high-resolution mass spectrometry to measure STING protein synthesis rates and degradation across different tissues.

Key outcome of the study

STING protein half-life varies significantly across tissues, ranging from 4 days in the colon and lymph nodes to 24 days in skeletal muscle. Despite increased STING abundance in Trex1 D18N mice, the protein’s degradation and resynthesis kinetics were similar to WT mice. The extent of interferon-stimulated gene transcription correlated with STING levels and was inversely proportional to its turnover rate.

Mouse model

Trex1 D18N Knockin mouse model, in which the endogenous Trex1 gene carries the D18N point mutation, leading to a chronic STING-dependent inflammatory response. This model mimics Aicardi-Goutières syndrome and is used to study autoimmune and inflammatory diseases.

TARGET:
Trex1
Three prime repair exonuclease 1

Keywords

Inflammation, STING pathway, Protein turnover, Aicardi-Goutières syndrome, Autoimmunity

Technical specifications

Knockin mouse model, Trex1 D18N mutation, STING-dependent inflammation, Metabolic labeling, Deuterium oxide tracing, Mass spectrometry, Point mutation

Related products

Catalogue product

No items found.

Customized product

Point mutation KI mouse

Use a point mutation mouse Knockin to circumvent complex phenotypes arising from complete Knockouts (e.g., signaling pathway problems, cross-reactivity).